Latest news
Porton Advanced Expands CDMO Services to Commercialization with China Manufacturing License - contractpharma.comcontractpharma.com · Wed, 05 Aug 2026 19:47:20 GMTPorton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTAltasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania - Business WireBusiness Wire · Tue, 04 Aug 2026 12:00:00 GMTHow customer expectations are reshaping the CDMO market - McKinsey & CompanyMcKinsey & Company · Mon, 03 Aug 2026 00:00:00 GMTCell and Gene Therapy CDMO Market Share, Outlook 2026-2035 - Global Market Insights Inc.Global Market Insights Inc. · Fri, 31 Jul 2026 12:42:06 GMTAsymBio Begins Construction on New Fengxian R&D Building to Enhance Biologics Services - SynBioBetaSynBioBeta · Tue, 28 Jul 2026 07:00:00 GMT